Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inga Zerr

Showing results (251-260 of 358) with videos related to

Pageof 36
Sort By:
Biomolecules|May 7, 2020
BAMBI and CHGA in Prion Diseases: Neuropathological Assessment and Potential Role as Disease BiomarkersÓscar López-Pérez, Marcos Bernal-Martín, Adelaida Hernaiz, et al.
Plos One|December 6, 2008
Urinary alpha1-antichymotrypsin: a biomarker of prion infectionGino Miele, Harald Seeger, Denis Marino, et al.
Alzheimer'S Research & Therapy|January 14, 2022
Plasma Lipocalin 2 in Alzheimer's disease: potential utility in the differential diagnosis and relationship with other biomarkersPeter Hermann, Anna Villar-Piqué, Matthias Schmitz, et al.
Redox Biology|April 2, 2024
Αnti-prion effects of anthocyaninsNikoletta Christoudia, Nikolaos Bekas, Eirini Kanata, et al.
Journal of Neurology|May 7, 2020
A new tetra-plex fluorimetric assay for the quantification of cerebrospinal fluid β-amyloid42, total-tau, phospho-tau and α-synuclein in the differential diagnosis of neurodegenerative dementiaDaniela Diaz-Lucena, Geòrgia Escaramis, Anna Villar-Piqué, et al.
BMC Neurology|September 23, 2006
Brain-derived proteins in the CSF: do they correlate with brain pathology in CJD?Constanze Boesenberg-Grosse, Walter J Schulz-Schaeffer, Monika Bodemer, et al.
Biomolecules|December 5, 2019
Evaluation of Human Cerebrospinal Fluid Malate Dehydrogenase 1 as a Marker in Genetic Prion Disease PatientsInga Zerr, Anna Villar-Piqué, Vanda Edit Schmitz, et al.
Translational Neurodegeneration|February 27, 2021
Ecto-GPR37: a potential biomarker for Parkinson's diseaseXavier Morató, Paula Garcia-Esparcia, Josep Argerich, et al.
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry|January 25, 2023
Synthesis, structural characterization and study of antioxidant and anti-PrP<sup>Sc</sup> properties of flavonoids and their rhenium(I)-tricarbonyl complexesPigi Glykofridi, Vassiliki-Eleni Tziouri, Konstantinos Xanthopoulos, et al.
Neurobiology of Aging|March 2, 2015
Rare structural genetic variation in human prion diseasesAna Lukic, James Uphill, Craig A Brown, et al.
Pageof 36

Showing results (251-260 of 358) with videos related to

Sort By:
Pageof 36
Biomolecules|May 7, 2020
BAMBI and CHGA in Prion Diseases: Neuropathological Assessment and Potential Role as Disease BiomarkersÓscar López-Pérez, Marcos Bernal-Martín, Adelaida Hernaiz, et al.
Plos One|December 6, 2008
Urinary alpha1-antichymotrypsin: a biomarker of prion infectionGino Miele, Harald Seeger, Denis Marino, et al.
Alzheimer'S Research & Therapy|January 14, 2022
Plasma Lipocalin 2 in Alzheimer's disease: potential utility in the differential diagnosis and relationship with other biomarkersPeter Hermann, Anna Villar-Piqué, Matthias Schmitz, et al.
Redox Biology|April 2, 2024
Αnti-prion effects of anthocyaninsNikoletta Christoudia, Nikolaos Bekas, Eirini Kanata, et al.
Journal of Neurology|May 7, 2020
A new tetra-plex fluorimetric assay for the quantification of cerebrospinal fluid β-amyloid42, total-tau, phospho-tau and α-synuclein in the differential diagnosis of neurodegenerative dementiaDaniela Diaz-Lucena, Geòrgia Escaramis, Anna Villar-Piqué, et al.
BMC Neurology|September 23, 2006
Brain-derived proteins in the CSF: do they correlate with brain pathology in CJD?Constanze Boesenberg-Grosse, Walter J Schulz-Schaeffer, Monika Bodemer, et al.
Biomolecules|December 5, 2019
Evaluation of Human Cerebrospinal Fluid Malate Dehydrogenase 1 as a Marker in Genetic Prion Disease PatientsInga Zerr, Anna Villar-Piqué, Vanda Edit Schmitz, et al.
Translational Neurodegeneration|February 27, 2021
Ecto-GPR37: a potential biomarker for Parkinson's diseaseXavier Morató, Paula Garcia-Esparcia, Josep Argerich, et al.
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry|January 25, 2023
Synthesis, structural characterization and study of antioxidant and anti-PrP<sup>Sc</sup> properties of flavonoids and their rhenium(I)-tricarbonyl complexesPigi Glykofridi, Vassiliki-Eleni Tziouri, Konstantinos Xanthopoulos, et al.
Neurobiology of Aging|March 2, 2015
Rare structural genetic variation in human prion diseasesAna Lukic, James Uphill, Craig A Brown, et al.
Pageof 36